Market Research Logo

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Markets

The global market for over the counter (OTC) drugs and dietary supplements reached $164.7 billion in 2016 and should reach $220.8 billion in 2021, with a compound annual growth rate (CAGR) of 6.0%.

Report Includes
An overview of the global markets for OTC drugs and dietary supplements
Analyses of global market trends, with data from 2015, 2016, and projections of CAGRs through 2021
Information about how pharmacies affect the OTC drug market
Analysis of new developments that will provide an opportunity to manufacturers and marketers of OTC medicines and dietary supplements to expand organically
Updates on the latest merger and acquistion activity
Coverage of how point of sales and channels of distribution drive sales of OTC drugs and dietary supplements
A look at key strategic initiatives for market penetration and expansion
Company profiles of major players in the field


Report Scope
The report considers only western or modern drugs for this report and excludes any other type of drugs such as alternative therapies.
This study aims at understanding the dynamics and forecasts for OTC drugs and dietary supplements markets worldwide and provides key market propositions within the next five-year period.

The report covers developed and emerging markets in order to help readers understand:
The current state of the OTC drugs and dietary supplements market and the key markets for its future development.
New regulations that will influence the development of the OTC drugs and dietary supplements market.
Market drivers of and threats to the OTC drugs and dietary supplements industry.
Major regional trends in the global OTC drugs and dietary supplements market.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
SCOPE OF REPORT
INTENDED AUDIENCE
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
GLOBAL OTC DRUG MARKETS BY LEADING THERAPEUTIC SEGMENTS, 2016 THROUGH 2021
SUMMARY TABLE A GLOBAL THERAPEUTIC MARKETS FOR OTC DRUGS, BY SEGMENT, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE A GLOBAL THERAPEUTIC MARKETS FOR OTC DRUGS, BY SEGMENT, 2015-2021 ($ MILLIONS)
GLOBAL DIETARY SUPPLEMENT MARKETS, 2016 THROUGH 2021
SUMMARY TABLE B REGIONAL MARKETS FOR DIETARY SUPPLEMENTS, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE B REGIONAL MARKETS FOR DIETARY SUPPLEMENTS, 2015-2021 ($ MILLIONS)
CHAPTER 3 OVERVIEW
EVOLUTION OF OTC DRUGS
KEY GROWTH FACTORS FOR OTC DRUGS AND DIETARY SUPPLEMENT MARKETS
FIGURE 1 KEY GROWTH FACTORS FOR OTC DRUGS
INDUSTRY DRIVERS FOR OTC DRUGS
PREVALENCE OF SELF-CARE
BURDEN ON PUBLIC HEALTH SYSTEM
RETAIN MARKET LEADERSHIP
RULES AND REGULATIONS FOR OTC DRUGS AND DIETARY SUPPLEMENTS
REGULATIONS FOR OTC DRUGS
REGULATIONS FOR DIETARY SUPPLEMENTS
MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENTS
WELL-DEVELOPED MARKETS
DEVELOPING MARKETS
UNDER-DEVELOPED MARKETS
CHAPTER 4 GLOBAL OTC DRUGS AND DIETARY SUPPLEMENT MARKETS
GLOBAL MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENTS 2016 THROUGH 2021
TABLE 1 GLOBAL MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENTS, THROUGH 2021 ($ MILLIONS)
REGIONAL MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENT MARKETS 2016 THROUGH 2021
TABLE 2 REGIONAL MARKETS FOR OTC DRUGS AND DIETARY SUPPLEMENTS THROUGH 2021 ($ MILLIONS)
GLOBAL SALES FORECAST FOR OTC DRUGS BY THERUPEUTIC CLASSIFICATION
TABLE 3 GLOBAL MARKET FOR OTC DRUGS, BY THERUPEUTIC CLASSIFICATION, THROUGH 2021 ($ MILLIONS)
GLOBAL OTC DRUGS AND DIETARY SUPPLEMENT MARKETS BY LOCATION OF SALES 2016 THROUGH 2021
TABLE 4 OTC DRUGS REVENUE BY LOCATION OF SALES, THROUGH 2021 ($ MILLIONS)
TABLE 5 DIETARY SUPPLEMENTS REVENUE BY LOCATION OF SALES, THROUGH 2021 ($ MILLIONS)
GLOBAL MARKET FORECAST FOR OTC DRUGS AND DIETARY SUPPLEMENTS BY SALES OUTLETS, THROUGH 2021
CHAPTER 5 OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN THE AMERICAS
OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN NORTH AMERICA 2016 THROUGH 2021
NORTH AMERICA OTC DRUGS MARKETS 2016 THROUGH 2021
TABLE 6 NORTH AMERICA OTC DRUG MARKETS, THROUGH 2021 ($ MILLIONS)
NORTH AMERICA DIETARY SUPPLEMENT MARKETS 2016 THROUGH 2021
TABLE 7 NORTH AMERICA DIETARY SUPPLEMENT MARKETS, THROUGH 2021 ($ MILLIONS)
NORTH AMERICA OTC DRUGS MARKETS BY THERAPEUTIC CLASSIFICATION 2016 THROUGH 2021
TABLE 8 NORTH AMERICA MARKETS BY THERAPEUTIC CLASSIFICATION, THROUGH 2021 ($ MILLIONS)
OTC DRUGS AND DIETARY SUPPLEMENTS IN THE U.S.
NORTH AMERICA OTC DRUGS MARKETS BY THERAPEUTIC CLASSIFICATION 2016-2021
TABLE 8 NORTH AMERICA MARKETS BY THERAPEUTIC CLASSIFICATION, THROUGH 2021 ($ MILLIONS)
VENDOR ECOSYSTEM FOR OTC DRUGS IN THE U.S.
MULTINATIONAL OTC DRUG MANUFACTURERS
STORE BRANDS
FMCG COMPANIES
REGULATIONS AND APPROVAL PROCESS: THE U.S.
Drugs Developed Under the OTC Drug Monograph Process
OTC Drug Review
OTC Monograph
OTC Drugs Developed Through the NDA Process
Updated List of Prescription to Over-the-Counter (OTC) Switches
TABLE 9 UPDATED LIST OF RX-TO-OTC SWITCHES IN THE U.S. FROM 2001 TO 2016
THE U.S. NONPRESCRIPTION SAFE-USE REGULATORY EXPANSION (NSURE)
INITIATIVE
THE U.S. OTC DRUGS AND DIETARY SUPPLEMENT MARKET 2016-2021
TABLE 10 THE U.S. OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021 ($ MILLIONS)
BRAZIL OTC DRUGS MARKET
BRAZIL OTC DRUGS MARKET 2016 THROUGH 2021
TABLE 11 BRAZIL OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021 ($ MILLIONS)
CHAPTER 6 THE OTC DRUG AND DIETARY SUPPLEMENT MARKETS IN
EUROPE
BREXIT EFFECT ON THE OTC DRUG MARKET IN EUROPE
REGULATIONS AND APPROVAL PROCESS IN EUROPE
National Procedure
Decentralized Procedure
Mutual Recognition Procedure
Centralized Procedure
SMART REGULATION 2015: EUROPE AS A SINGLE MARKET
OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN EUROPE 2016 - 2021
EUROPEAN OTC DRUGS AND DIETARY SUPPLEMENT MARKETS 2016 - 2021
TABLE 12 EUROPEAN OTC DRUG MARKETS, THROUGH 2021 ($ MILLIONS)
OTC DRUGS AND DIETARY SUPPLEMENT MARKETS: WESTERN EUROPE
THROUGH 2021
TABLE 13 EUROPEAN OTC DRUG MARKETS BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021 ($ MILLIONS)
THE U.K. OTC DRUG MARKET
THE REGULATIONS AND APPROVAL PROCESS IN THE U.K.
Better Regulation of Over-the-Counter Drugs Initiative (BROMI) U.K.
POM TO P RECLASSIFICATIONS UP TO OCTOBER 2016
TABLE 14 U.K. POM TO P RECLASSIFICATIONS UP TO OCTOBER 2016
TABLE 15 P TO GSL RECLASSIFICATIONS UP TO OCTOBER 2016
POM TO P RECLASSIFICATIONS IN THE U.K. APPROVED FROM 2010 TO 2015
TABLE 16 RECENT POM TO P RECLASSIFICATIONS AND NONPRESCRIPTION MARKETING AUTHORIZATIONS:
U.K., 2010-2015
TABLE 17 RECENT P TO GSL RECLASSIFICATIONS AND NONPRESCRIPTION
MARKETING AUTHORIZATIONS - U.K., 2011-2015
U.K. OTC DRUGS AND DIETARY SUPPLEMENT MARKET 2016 THROUGH 2021
TABLE 18 THE U.K. OTC DRUG MARKET, BY THERAPEUTIC CLASSIFICATION, THROUGH 2021 ($ MILLIONS)
GERMAN OTC DRUG AND DIETARY SUPPLEMENTS MARKET
THE REGULATIONS AND APPROVAL PROCESS IN GERMANY
OTC DRUG SWITCHES IN GERMANY FROM 2005 TO 2016
TABLE 19 OTC DRUG SWITCHES IN GERMANY FROM 2005 TO 2016
GERMAN OTC MARKET 2016 THROUGH 2021
TABLE 20 GERMANY OTC DRUG MARKETS BY THERAPEUTIC
CLASSIFCATIONS, THROUGH 2021 ($ MILLIONS)
FRANCE'S OTC DRUGS MARKET 2016 THROUGH 2021
TABLE 21 FRANCE OTC DRUG MARKETS BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021 ($ MILLIONS)
OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN CENTRAL AND EASTERN
EUROPE
TABLE 22 CCE OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFCATIONS, THROUGH 2021 ($ MILLIONS)
THE RUSSIAN OTC DRUG MARKET 2016 THROUGH 2021
TABLE 23 RUSSIAN OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021 ($ MILLIONS)
THE POLISH OTC DRUG MARKET 2016 THROUGH 2021
TABLE 24 POLISH OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021 ($ MILLIONS)
CHAPTER 7 OTC DRUGS AND DIETARY SUPPLEMENT MARKETS IN
ASIA-PACIFIC
APAC OTC DRUGS MARKETS 2016 THROUGH 2021
TABLE 25 APAC OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021 ($ MILLIONS)
JAPAN'S OTC DRUGS MARKET
The Regulation and Approval Process in Japan
Reviews Conducted for OTC Drugs In Japan, by Fiscal Year
TABLE 26 REVIEWS CONDUCTED FOR OTC DRUGS IN JAPAN, BY FISCAL YEAR, 2011-2015
First Kind Pharmaceutical Newly Approved - Japan's OTC Pharmaceutical
Sales System
TABLE 27 UPDATED LIST OF OTC TO FIRST KIND PHARMACEUTICAL
DRUGS IN JAPAN, NOV. 2007-MARCH 2016
JAPAN'S OTC DRUGS MARKET 2016 THROUGH 2021
TABLE 28 JAPAN OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021 ($ MILLIONS)
CHINA OTC DRUG MARKETS 2016 THROUGH 2021
THE REGULATION AND APPROVAL PROCESS: CHINA
New Amendments in Regulating Drug Advertising in 2015
CHINA - OTC DRUGS MARKET 2016 THROUGH 2021
TABLE 29 CHINA OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021 ($ MILLIONS)
INDIA OTC DRUG MARKETS
INDIA: REGULATION AND APPROVAL PROCESSES
INDIA - OTC DRUGS MARKET 2016 THROUGH 2021
TABLE 30 INDIA OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021 ($ MILLIONS)
AUSTRALIA AND NEW ZEALAND'S OTC DRUGS MARKET
Regulation and Approval Process: Australia
NEW ZEALAND
JOINT AUSTRALIAN AND NEW ZEALAND PHASED IMPLEMENTATION PLAN 2013
N2 Applications (Using OTC Monographs) Version1, September 2013
Level N3, N4 and N5 Applications
AUSTRALIA AND NEW ZEALAND: OTC DRUGS MARKET 2016 THROUGH
2021
TABLE 31 AUSTRALIA AND NEW ZEALAND OTC DRUG MARKETS, BY THERAPEUTIC CLASSIFICATIONS, THROUGH 2021 ($ MILLIONS)
CHAPTER 8 GLOBAL MARKET FORECAST FOR OTC DRUGS BY THERUPEUTIC CLASSIFICATION
OTC ANALGESICS/ANTIPYRETICS MARKETS 2021
ACETAMINOPHEN
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)
MARKET FORECASTS 2016 THROUGH 2021
TABLE 32 GLOBAL MARKET FORECAST FOR OTC ANALGESICS AND ANTIPYRETICS, THROUGH 2021 ($ MILLIONS)
OTC ANTIHISTAMINE AND COUGH AND COLD DRUGS MARKETS 2021
ANTIHISTAMINES
COUGH AND COLD REMEDIES
Nasal Decongestants
Cough Remedies
GLOBAL MARKET FORECASTS THROUGH 2021
TABLE 33 GLOBAL MARKET FORECAST FOR OTC ANTIHISTAMINE AND COUGH AND COLD, THROUGH 2021 ($ MILLIONS)
OTC GASTROINTESTINAL PRODUCTS MARKETS 2021
GASTROINTESTINAL DISORDER TREATMENTS
Antacids
H2 Blockers
Proton Pump Inhibitors (PPIs)
GLOBAL MARKET FORECAST FOR THROUGH 2021
TABLE 34 GLOBAL MARKET FORECAST FOR OTC GASTROINTESTINAL PRODUCTS, THROUGH 2021 ($ MILLIONS)
OTC DERMATOLOGICAL DRUGS MARKETS 2021
SKINCARE AND DERMATOLOGICAL DRUGS
Acne Treatments
Psoriasis
GLOBAL MARKET FORECAST THROUGH 2021
TABLE 35 GLOBAL MARKET FORECAST FOR OTC DERMATOLOGICAL DRUGS, THROUGH 2021 ($ MILLIONS)
OTC ORAL MEDICAL CARE PRODUCTS MARKETS 2021
ORAL MEDICAL CARE
Oral Debriding Agents and Wound Cleansers
Treatments for Dental Carries
Treatments on Gum Diseases
Treatments for Cold Sores
GLOBAL MARKET FORECAST FOR THROUGH 2021
TABLE 36 GLOBAL MARKET FORECAST FOR OTC ORAL MEDICAL CARE PRODUCTS THROUGH 2021 ($ MILLIONS)
GLOBAL MARKET FORECAST FOR OTC EYE CARE PRODUCTS
EYE CARE PRODUCTS
Treatments for Dry Eye
Ocular Allergy Symptoms
Ocular/Eye Vitamins
Eyelid Hygiene
Contact Lenses Solution
Dry Eye
GLOBAL MARKET FORECAST THROUGH 2021
TABLE 37 GLOBAL MARKET FORECAST FOR OTC EYE CARE PRODUCTS, THROUGH 2021 ($ MILLIONS)
OTC SMOKING CESSATION PRODUCTS MARKETS 2021
SMOKING CESSATION
Nicotine Gum
Nicotine Lozenges
Nicotine Patch
GLOBAL MARKET FORECAST FOR OTC SMOKING CESSATION PRODUCTS BY REGION THROUGH 2021
TABLE 38 GLOBAL MARKET FORECAST FOR OTC SMOKING CESSATION PRODUCTS, BY REGION, THROUGH 2021 ($ MILLIONS)
OTC DIETARY SUPPLEMENTS (VMS) MARKETS 2021
EATING DISORDERS
TREATMENTS FOR VITAMINS AND MINERAL DEFICIENCY
VITAMINS AND MINERAL SUPPLEMENTS (VMS)
GLOBAL MARKET FORECAST THROUGH 2021
TABLE 39 GLOBAL MARKET FORECAST FOR OTC DIETARY SUPPLEMENT PRODUCTS, BY REGION, THROUGH 2021 ($ MILLIONS)
CHAPTER 9 OTC DRUG INDUSTRY ROADMAP
THE PRACTICE OF BUYING OTC DRUGS
ROLE OF PHARMACY IN OTC DRUGS
REGULATORY INFLUENCE ON OTC DRUG MARKET
KEY STRATEGIC INITIATIVES FOR MARKET PENETRATION AND EXPANSION
ACQUISITION OF MARKETING AUTHORIZATION: KEY MARKET PENETRATION
AND EXPANSION STRATEGY
EXPANSIONS, PARTNERSHIPS AND JOINT VENTURES
THIRD-PARTY CONTRACTING
DRIVERS OF AND BARRIERS TO THE OTC DRUG INDUSTRY
RECENT DRIVERS FOR THE OTC DRUGS AND DIETARY SUPPLEMENT
MARKET
STRENGTHS, WEAKNESSES, OPPORTUNITIES AND THREATS (SWOT) ANALYSIS
OF THE OTC DRUG AND DIETARY SUPPLEMENT INDUSTRY
TABLE 40 SWOT ANALYSIS OF THE OTC DRUG AND DIETARY SUPPLEMENT
INDUSTRY
CHAPTER 10 COMPANY PROFILES
ALACER CORP.
ALCON INC.
ALFRESA PHARMA CORPORATION
ALKALON A/S
ALLIANCE HEALTHCARE
ALLIANCE HEALTHCARE DEUTSCHLAND
ALLIANCE HEALTHCARE FRANCE
ALLERGAN, PLC.
ALTICOR
NUTRILITE
ARKOPHARMA PHARMACEUTICAL LABORATORIES (LABORATOIRES
PHARMACEUTIQUES)
ASPEN HOLDINGS
ASPEN PHARMACARE AUSTRALIA PTY. LTD.
BAUSCH & LOMB
BAYER HEALTHCARE AG
BOEHRINGER INGELHEIM GMBH
CARMA LABORATORIES, INC.
CHATTEM INC.
CILAG AG
COLGATE-PALMOLIVE COMPANY
DAIICHI SANKYO CO., LTD.
DERMA SCIENCES
EYESCIENCE LABS
FERTIN PHARMA A/S
GABA GMBH, PC
GABA SCHWEIZ
GALDERMA S.A.
GEMINI PHARMACEUTICALS, INC.
GENOMMA LAB INTERNATIONAL
GENOMMA LAB USA
GLAXOSMITHKLINE PLC
HISAMITSU PHARMACEUTICAL CO., INC.
JOHNSON & JOHNSON
KOWA COMPANY, LTD.
LAKE CONSUMER PRODUCTS, INC.
MANX HEALTHCARE LIMITED
MCM KLOSTERFRAU VERTRIEBS GMBH (KLOSTERFRAU HEALTHCARE GROUP)
MEDA AB
MELALEUCA, INC.
MERCK CORPORATE HEADQUARTERS
MERCK CANADA
MERCK CHINA
MERZ PHARMA
MOCHIDA PHARMACEUTICAL CO., LTD.
NEPENTES SA/NEPENTES PHARMA SP. Z O.O.
NEUTROGENA CORP.
NORTHEAST PHARMACEUTICAL GROUP CO. LTD
NOVARTIS INTERNATIONAL AG
NOW FOODS
PERRIGO PLC
PFIZER INC.
PGT HEALTHCARE (DIVISION OF PROCTER & GAMBLE)
PHARMAVITE LLC
PIERRE FABRE PHARMACEUTICALS INC.
PIRAMAL HEALTHCARE LTD
PRESTIGE BRANDS HOLDINGS, INC.
RECKITT BENCKISER PLC.
RECKITT BENCKISER (NORTH AMERICA) INC.
RECORDATI PHARMA GMBH
REVOLYMER (U.K.) LTD
SAGE PRODUCTS LLC
SANOFI
SATO PHARMACEUTICAL CO., LTD.
SHAKLEE CORPORATION
STADA ARZNEIMITTEL AG
SWISSE WELLNESS PTY LTD.
TAISHO PHARMACEUTICAL HOLDINGS
TAKEDA PHARMACEUTICALS LTD.
TISSO NATURPRODUKTE GMBH
WELLSPRING PHARMACEUTICAL CORPORATION
ZEAVISION, LLC
CHAPTER 11 APPENDIX I
MARKET DEFINITIONS
OTC DRUGS
DIETARY SUPPLEMENTS (VMS)
COMMON ADMINISTRATION METHODS FOR OTC DRUGS
TOPICAL ADMINISTRATION
Lotion
Cream
Ointment
Gel
Transdermal Patch
ORAL ADMINISTRATION
Tablets
Capsules
Medicinal Syrups
Medicated Chewing Gums
CHAPTER 12 APPENDIX II
SMOKING CESSATION INITIATIVES
HIGH RATE OF SMOKERS QUITTING IN DEVELOPED COUNTRIES
DECREASE IN SMOKING RATES AT SATURATION POINT IN DEVELOPED
MARKETS
SMOKING RATES ARE INCREASING IN DEVELOPING MARKETS
STRATEGIC INITIATIVES TO INCREASE SMOKING CESSATION IN DEVELOPING COUNTRIES
DEVELOPING AND POOR COUNTRIES SIGN WHO FCTC TREATY
WHO FCTC PROGRESS REPORT 2012
TABLE 41 ARTICLES REPORTED TO HAVE HIGHEST IMPLEMENTATION RATES IN 2012 WHO FCTC PROGRESS REPORT (%)
TABLE 42 ARTICLES REPORTED MODERATE IMPLEMENTATION RATES: 2012 WHO FCTC PROGRESS REPORT (%)
TABLE 43 ARTICLES REPORTED LOWEST IMPLEMENTATION RATES: 2012 WHO FCTC PROGRESS REPORT (%)
FIGURE 2 GLOBAL IMPLEMENTATION OF ARTICLES OF 2012 WHO FCTC PROGRESS REPORT (%)
TABLE 44 GLOBAL IMPLEMETATION OF FCTC ARTICLES: 2012 REPORT
Implementation of Article 14 in 2012
TABLE 45 GLOBAL IMPLEMENTATION OF ARTICLE 14 OF FCTC
Political and Legal Interventions Influence Markets
TABLE 46 INITIATIVES IMPLEMENTED BY PARTIES TO FCTC TREATY IN 2012 (%)
Socioeconomic Factors of Smoking
TABLE 47 PROJECTED GLOBAL CAUSE OF DEATH BY DISEASE (%)
TABLE 48 PUBLIC HEALTH BURDEN DUE TO SMOKING-RELATED DISEASES ($ BILLIONS)
Technological Developments Concerning Smoking
FIGURE 3 ONGOING STUDIES, BY REGION (NO. OF STUDIES)
CHAPTER 13 APPENDIX III
OTC MARKETS 2013 THROUGH 2018
TABLE 49 GLOBAL MARKET FOR OTC DRUGS AND DIETARY SUPPLEMENTS THROUGH 2018 ($ MILLIONS)
FIGURE 4 GLOBAL MARKET FOR OTC DRUGS AND DIETARY SUPPLEMENTS, 2011-2018 ($ MILLIONS)
HIGHLIGHTS OF THE YEAR 2012
TRENDS IN OTC DRUGS AND DIETARY SUPPLEMENTS THROUGH 2018
FORECAST TRENDS IN OTC DRUGS BY THERAPEUTIC CLASS THROUGH 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report